18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
and 9 12 9 12 O
older 13 18 13 18 O
( 19 20 19 20 O
Japan-20 20 28 20 28 O
years 29 34 29 34 I-lower_bound
and 35 38 35 38 O
older 39 44 39 44 O
) 44 45 44 45 O

Active 0 6 46 52 O
or 7 9 53 55 O
prior 10 15 56 61 O
documented 16 26 62 72 O
autoimmune 27 37 73 83 B-chronic_disease
or 38 40 84 86 O
inflammatory 41 53 87 99 B-chronic_disease
disease 54 61 100 107 I-chronic_disease
with 62 66 108 112 O
some 67 71 113 117 O
exceptions 72 82 118 128 O

Advanced 0 8 129 137 O
HCC 9 12 138 141 B-cancer
with 13 17 142 146 O
diagnosis 18 27 147 156 O
confirmed 28 37 157 166 O
pathologically 38 52 167 181 O
or 53 55 182 184 O
with 56 60 185 189 O
noninvasive 61 72 190 201 O
methods 73 80 202 209 O

Any 0 3 210 213 O
concurrent 4 14 214 224 O
chemotherapy 15 27 225 237 B-treatment
, 27 28 237 238 O
immunotherapy 29 42 239 252 B-treatment
, 42 43 252 253 O
or 44 46 254 256 O
biologic 47 55 257 265 B-treatment
or 56 58 266 268 I-treatment
hormonal 59 67 269 277 I-treatment
therapy 68 75 278 285 I-treatment
for 76 79 286 289 O
cancer 80 86 290 296 B-cancer
treatment 87 96 297 306 B-treatment

Ascites 0 7 307 314 B-chronic_disease
requiring 8 17 315 324 O
non 18 21 325 328 B-treatment
- 21 22 328 329 I-treatment
pharmacologic 22 35 329 342 I-treatment
intervention 36 48 343 355 I-treatment
( 49 50 356 357 O
eg 50 52 357 359 O
, 52 53 359 360 O
paracentesis 54 66 361 373 B-treatment
) 66 67 373 374 O
to 68 70 375 377 O
maintain 71 79 378 386 O
symptomatic 80 91 387 398 O
control 92 99 399 406 O
, 99 100 406 407 O
within 101 107 408 414 O
6 108 109 415 416 B-upper_bound
months 110 116 417 423 I-upper_bound
prior 117 122 424 429 I-upper_bound
to 123 125 430 432 O
the 126 129 433 436 O
first 130 135 437 442 O
scheduled 136 145 443 452 O
dose 146 150 453 457 O

Confirmed 0 9 458 467 O
HCC 10 13 468 471 B-cancer
based 14 19 472 477 O
on 20 22 478 480 O
histopathological 23 40 481 498 O
findings 41 49 499 507 O
from 50 54 508 512 O
tumor 55 60 513 518 B-cancer
tissues 61 68 519 526 O

Current 0 7 527 534 O
or 8 10 535 537 O
prior 11 16 538 543 O
use 17 20 544 547 O
of 21 23 548 550 O
immunosuppressive 24 41 551 568 B-treatment
medication 42 52 569 579 I-treatment
within 53 59 580 586 O
14 60 62 587 589 B-upper_bound
days 63 67 590 594 I-upper_bound
with 68 72 595 599 O
some 73 77 600 604 O
exceptions 78 88 605 615 O

GI 0 2 616 618 B-chronic_disease
Bleeding 3 11 619 627 I-chronic_disease
( 12 13 628 629 O
eg 13 15 629 631 O
, 15 16 631 632 O
esophageal 17 27 633 643 B-chronic_disease
varices 28 35 644 651 I-chronic_disease
or 36 38 652 654 O
ulcer 39 44 655 660 B-chronic_disease
bleeding 45 53 661 669 I-chronic_disease
) 53 54 669 670 O
within 55 61 671 677 O
12 62 64 678 680 B-upper_bound
months 65 71 681 687 I-upper_bound

Have 0 4 688 692 O
either 5 11 693 699 O
progressed 12 22 700 710 O
on 23 25 711 713 O
, 25 26 713 714 O
are 27 30 715 718 O
intolerant 31 41 719 729 O
to 42 44 730 732 O
, 44 45 732 733 O
or 46 48 734 736 O
refused 49 56 737 744 O
treatment 57 66 745 754 B-treatment
with 67 71 755 759 O
sorafenib 72 81 760 769 B-treatment
or 82 84 770 772 O
another 85 92 773 780 O
approved 93 101 781 789 O
TKI 102 105 790 793 B-treatment

Have 0 4 794 798 O
not 5 8 799 802 O
received 9 17 803 811 O
any 18 21 812 815 O
prior 22 27 816 821 B-treatment
systemic 28 36 822 830 I-treatment
therapy 37 44 831 838 I-treatment
for 45 48 839 842 O
HCC 49 52 843 846 B-cancer

Hepatic 0 7 847 854 B-chronic_disease
encephalopathy 8 22 855 869 I-chronic_disease
within 23 29 870 876 O
past 30 34 877 881 B-upper_bound
12 35 37 882 884 I-upper_bound
months 38 44 885 891 I-upper_bound
or 45 47 892 894 O
requirement 48 59 895 906 O
for 60 63 907 910 O
medications 64 75 911 922 B-treatment
to 76 78 923 925 O
prevent 79 86 926 933 O
or 87 89 934 936 O
control 90 97 937 944 O
encephalopathy 98 112 945 959 O

Immunotherapy 0 13 960 973 B-treatment
- 13 14 973 974 O
na√Øve 14 19 974 979 O

Main 0 4 980 984 O
portal 5 11 985 991 B-chronic_disease
vein 12 16 992 996 I-chronic_disease
thrombosis 17 27 997 1007 I-chronic_disease
( 28 29 1008 1009 O
Vp4 29 32 1009 1012 O
) 32 33 1012 1013 O
as 34 36 1014 1016 O
documented 37 47 1017 1027 O
on 48 50 1028 1030 O
imaging 51 58 1031 1038 B-treatment

Male 0 4 1039 1043 B-gender
or 5 7 1044 1046 I-gender
female 8 14 1047 1053 I-gender
subjects 15 23 1054 1062 I-gender

Prior 0 5 1063 1068 O
exposure 6 14 1069 1077 O
to 15 17 1078 1080 O
immune 18 24 1081 1087 B-treatment
- 24 25 1087 1088 I-treatment
mediated 25 33 1088 1096 I-treatment
therapy 34 41 1097 1104 I-treatment

